← Evidence library

BIB_182

Long GV et al. Combination nivolumab + ipilimumab vs nivolumab alone in melanoma brain metastases (ABC trial). Lancet Oncology 2018;19(5):672–681. PMID 29602646. Confirms intracranial activity of combination ICI. [Tasks: 18] Tier: 1 Grade: A Retrieved: 2026-05-07

Evidence grade

A

Tier

1

Cited by tasks

18

Identifiers

PMID:29602646

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_182/findings.md (research corpus). This page is a short context summary — not individualised medical advice.